Trial Profile
Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 23 Jun 2018 According to an Eli Lilly media release, data from three phase Ib studies, including this trial will be presented at the 78th Scientific Session of the American Diabetes Association (ADA).
- 13 Jun 2017 Results of first part of this study (n=30) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 28 Jul 2016 Status changed from active, no longer recruiting to completed.